openPR Logo
Press release

Lawsuit filed for Investors in shares of Icahn Enterprises L.P. (NASDAQ: IEP)

05-17-2023 08:20 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

A lawsuit was filed on behalf of investors in Icahn Enterprises L.P. (NASDAQ: IEP) shares over alleged securities laws violations.

A lawsuit was filed on behalf of investors in Icahn Enterprises L.P. (NASDAQ: IEP) shares over alleged securities laws violations.

An investor, who purchased shares of Icahn Enterprises L.P. (NASDAQ: IEP), filed a lawsuit over alleged violations of Federal Securities Laws by Icahn Enterprises L.P..

Investors who purchased shares of Icahn Enterprises L.P. (NASDAQ: IEP) have certain options and for certain investors are short and strict deadlines running. Deadline: July 10, 2023. NASDAQ: IEP investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

Sunny Isles Beach, FL based Icahn Enterprises L.P., through its subsidiaries, operates in investment, energy, automotive, food packaging, real estate, home fashion, and pharma businesses in the United States and Internationally.

On May 2, 2023, Hindenburg Research released a report outlining its concerns regarding Icahn Enterprises L.P.. The firm alleges that Icahn Enterprises L.P. units are inflated by up to 75% stating, "(1) IEP trades at a 218% premium to its last reported net asset value (NAV), vastly higher than all comparables (2) we've uncovered clear evidence of inflated valuation marks for IEP's less liquid and private assets (3) the company has suffered additional performance losses year to date following its last disclosure."

Shares of Icahn Enterprises L.P. (NASDAQ: IEP) declined from $51.34 per share on May 1, 2023 to as low as $28.29 per share on May 04, 2023.

On May 10, 2023, before the market opened, Icahn Enterprises L.P. filed its Quarterly Report on Form 10-Q with the SEC for the period ended March 31, 2023. Therein, the Company stated that the U.S. Attorney's office for the Southern District of New York contacted Icahn Enterprises on May 3, 2023 seeking production of information relating to the Company, certain of its affiliates' "corporate governance, capitalization, securities offerings, dividends, valuation, marketing materials, due diligence and other materials." Icahn Enterprises L.P. claimed it is "cooperating with the request" and is "providing documents in response to the voluntary request for information."

The plaintiff claims that between August 2, 2018 and May 9, 2023, the Defendants failed to disclose to investors that Icahn Enterprises was inflating its net asset value, that the Company was using money taken in from new investors to pay out dividends to old investors, that, as a result, the Company would become the subject of criminal and/or regulatory scrutiny, and that as a result of the foregoing, Defendant's positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.

Those who purchased shares of Icahn Enterprises L.P. (NASDAQ: IEP) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Lawsuit filed for Investors in shares of Icahn Enterprises L.P. (NASDAQ: IEP) here

News-ID: 3056352 • Views:

More Releases from Shareholders Foundation

Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: JHX) should contact the Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements. Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT)
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced. Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherapeutics (NASDAQ: MLTX)
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements. Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc. Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -

All 5 Releases


More Releases for Icahn

United States Medical Rehabilitation Services Market to hit US$ 412.66 Billion b …
"Global Medical Rehabilitation Services Market reached US$ 260.74 billion in 2024 and is expected to reach US$ 412.66 billion by 2032, growing at a CAGR of 6.3% during the forecast period 2025-2032" As per DataM intelligence research report Download your exclusive sample report today: (corporate email gets priority access): https://www.datamintelligence.com/download-sample/medical-rehabilitation-services-market?sp United States: Recent Industry Developments ✅ In September 2025, Select Medical expanded its rehabilitation network with new outpatient centers specializing in post-acute and
Cryoglobulinemia Market Revenue to Expand Significantly by 2032, States DelveIns …
DelveInsight's "Cryoglobulinemia Market Insights, Epidemiology, and Market Forecast-2032′′ report offers an in-depth understanding of the Cryoglobulinemia, historical and forecasted epidemiology as well as the Cryoglobulinemia market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan. The latest healthcare forecast report provides an in-depth analysis of Cryoglobulinemia, offering comprehensive insights into the Cryoglobulinemia revenue trends, prevalence, and treatment landscape. The report delves into key Cryoglobulinemia
QSYMIA (Phentermine- topiramate) Market Size and Share Analysis Across 7MM and C …
DelveInsight has released a comprehensive report titled "QSYMIA (Phentermine- topiramate) Market Forecast" offering a thorough examination and predictive insights into the QSYMIA (Phentermine- topiramate) market landscape until 2032 across the seven major markets (7MM), encompassing the United States, EU4 (Germany, France, Italy, and Spain), the United Kingdom, and Japan. The extensive report offers a thorough examination of the market potential and market share of QSYMIA (Phentermine- topiramate) in the therapeutics landscape
Investigation announced for Investors in Icahn Enterprises L.P. (NASDAQ: IEP) ov …
An investigation was announced over potential breaches of fiduciary duties by certain directors and officers of Icahn Enterprises L.P.. Investors who are current long term investors in Icahn Enterprises L.P. (NASDAQ: IEP) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: IEP stocks follows a lawsuit filed against Icahn
Investigation announced for Investors in shares of Icahn Enterprises L.P. (NASDA …
An investigation was announced for investors of Icahn Enterprises L.P. (NASDAQ: IEP) shares over potential securities laws violations by Icahn Enterprises L.P. and certain of its directors and officers. Investors who purchased shares of Icahn Enterprises L.P. (NASDAQ: IEP), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on possible claims on behalf of purchasers of the
Automotive Frame Machine Market Evaluation Targets Advancement Anticipated until …
The growth of the automotive frame machines market is mainly attributed to the increasing use of automotive frame machines as an automotive collision repair equipment. A mounting number of auto service businesses and stakeholders in the automotive aftermarket are adopting automotive frame machines with innovative features and higher quality. In addition to the growing demand from market players in the automotive aftermarket, increasing growth of the automotive repair industry is